Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cystic Renal Disease”

290 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 290 results

Large-scale testing (Phase 3)Study completedNCT00426153
What this trial is testing

Octreotide in Severe Polycystic Liver Disease

Who this might be right for
Polycystic Kidney, Autosomal DominantPolycystic Liver DiseaseHepatomegaly+3 more
Mayo Clinic 42
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Large-scale testing (Phase 3)WithdrawnNCT04786574
What this trial is testing

See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Who this might be right for
Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Otsuka Pharmaceutical Development & Commercialization, Inc.
Not applicableStudy completedNCT02250287
What this trial is testing

New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseKidney Disease
Mayo Clinic 20
Not applicableEnded earlyNCT00934791
What this trial is testing

Polycystic Liver Disease in Kidney Transplant

Who this might be right for
Polycystic Liver Disease
Mayo Clinic 2
Testing effectiveness (Phase 2)Study completedNCT03196076
What this trial is testing

Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension

Who this might be right for
Chronic Kidney DiseasesCystic Kidney Disease
University of North Carolina, Chapel Hill 25
Not applicableEnrolling By InvitationNCT06841224
What this trial is testing

The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease

Who this might be right for
Peritoneal DialysisPolycystic Kidney Diseases
Peking University First Hospital 30
Testing effectiveness (Phase 2)UnknownNCT01932450
What this trial is testing

Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseHypertension
Mei changlin 100
Not applicableStudy completedNCT04407481
What this trial is testing

PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)

Who this might be right for
Polycystic Kidney Disease, AdultPolycystic Kidney, Autosomal Dominant
University of Colorado, Denver 22
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Large-scale testing (Phase 3)Ended earlyNCT00920309
What this trial is testing

Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Yale University 21
Large-scale testing (Phase 3)Looking for participantsNCT07280585
What this trial is testing

STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney, Autosomal Dominant
University of Cologne 420
Testing effectiveness (Phase 2)Study completedNCT05190744
What this trial is testing

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

Who this might be right for
Autosomal Dominant Polycystic Kidney DiseaseNephrogenic Diabetes InsipidusAcquired Nephrogenic Diabetes Insipidus+1 more
Mayo Clinic 36
Early research (Phase 1)Not Yet RecruitingNCT06658964
What this trial is testing

Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects

Who this might be right for
ADPKD (autosomal Dominant Polycystic Kidney Disease)
Jemincare 48
Testing effectiveness (Phase 2)Looking for participantsNCT05478083
What this trial is testing

A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease

Who this might be right for
Polycystic Liver DiseaseAutosomal Dominant Polycystic Kidney
University Medical Center Groningen 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Not applicableNo Longer AvailableNCT00764543
What this trial is testing

Ambulatory Blood Pressure Measurement in Children With Congenital Urine Flow Obstruction

Who this might be right for
HydronephrosisMulticystic-dysplastic Kidney
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT02527863
What this trial is testing

Effect of the Aquaretic Tolvaptan on Nitric Oxide System

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Regional Hospital Holstebro 18
Large-scale testing (Phase 3)Active Not RecruitingNCT05281328
What this trial is testing

A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD

Who this might be right for
Polycystic Liver Disease
Camurus AB 71
Load More Results